3 Undervalued Growth Stocks You Can Buy Now | The Motley Fool


🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
These companies are growing revenue faster than the rate of increase of the U.S. economy.

3 Undervalued Growth Stocks You Can Buy Now
In the ever-evolving landscape of the stock market, investors are constantly on the lookout for opportunities that combine strong growth potential with attractive valuations. As we navigate through 2025, with economic uncertainties lingering from inflation pressures, interest rate fluctuations, and geopolitical tensions, the appeal of undervalued growth stocks has never been more pronounced. These are companies that have demonstrated robust expansion in their respective sectors but are currently trading at prices that don't fully reflect their future prospects. This mismatch often arises from short-term market overreactions, sector-wide sell-offs, or temporary business hiccups, creating buying opportunities for patient investors.
According to market analysts, the current environment—marked by a potential slowdown in consumer spending and a shift toward value investing—has pushed several high-growth names into undervalued territory. Metrics like price-to-earnings (P/E) ratios, price-to-sales (P/S) ratios, and forward earnings estimates are key indicators here. Stocks with P/E ratios below their historical averages or industry peers, coupled with projected revenue growth exceeding 20% annually, fit the bill perfectly. In this article, we'll dive into three such undervalued growth stocks that savvy investors should consider adding to their portfolios right now. These picks span diverse industries, from technology and e-commerce to healthcare, offering diversification while promising substantial upside.
1. Shopify (SHOP): The E-Commerce Powerhouse Poised for a Rebound
Shopify Inc. (NYSE: SHOP) stands out as a prime example of a growth stock that's been unfairly punished by the market. As a leading provider of e-commerce platforms, Shopify empowers businesses of all sizes to set up online stores, manage payments, and handle logistics seamlessly. Founded in 2006, the company has grown exponentially, especially during the pandemic-driven surge in online shopping. However, recent headwinds, including a slowdown in e-commerce growth post-COVID and increased competition from giants like Amazon, have led to a significant pullback in its stock price.
Currently trading at around $70 per share—down more than 50% from its 2021 peak—Shopify boasts a forward P/E ratio of approximately 45, which is notably lower than its historical average of over 100 during peak growth periods. This valuation seems undervalued when you consider the company's impressive fundamentals. In its latest quarterly earnings, Shopify reported a 25% year-over-year revenue increase to $2.1 billion, driven by a growing merchant base and expansions into international markets. Gross merchandise volume (GMV) surged to $67 billion, underscoring the platform's stickiness and scalability.
What makes Shopify a compelling growth story? The global e-commerce market is projected to expand at a compound annual growth rate (CAGR) of 14% through 2030, according to Statista. Shopify is well-positioned to capture a larger share, thanks to innovations like its AI-powered tools for personalized shopping experiences and integrations with social media platforms for seamless selling. Moreover, the company's subscription-based model ensures recurring revenue, with gross margins hovering around 50%. Analysts forecast earnings per share (EPS) to grow by 30% annually over the next five years, potentially driving the stock to $150 or higher if market conditions improve.
Risks exist, of course—economic downturns could dampen small business spending, and regulatory scrutiny on data privacy might add costs. Yet, with a strong balance sheet featuring over $5 billion in cash and minimal debt, Shopify has the firepower to weather storms and invest in growth initiatives. For long-term investors, this dip represents a golden entry point into a company that's essentially the backbone of the digital economy.
2. Teladoc Health (TDOC): Revolutionizing Healthcare in a Post-Pandemic World
Shifting gears to the healthcare sector, Teladoc Health Inc. (NYSE: TDOC) is another undervalued gem with tremendous growth runway. As a pioneer in telemedicine, Teladoc connects patients with doctors via virtual platforms, offering services ranging from primary care to mental health support. The company exploded in popularity during the COVID-19 era, but as in-person visits resumed, its stock plummeted from highs of over $300 in 2021 to around $10 today—a staggering 97% decline.
This sell-off has left Teladoc trading at a forward P/S ratio of just 1.2, compared to the healthcare tech industry's average of 4-5. Such a low multiple is striking given Teladoc's solid performance: Recent quarters showed revenue growth of 10%, reaching $650 million, with membership expanding to 90 million users. The acquisition of Livongo in 2020 has bolstered its chronic care management offerings, creating synergies that are only beginning to materialize.
The growth thesis for Teladoc is rooted in the secular shift toward digital health solutions. Aging populations, rising healthcare costs, and a shortage of physicians are driving demand for telehealth, which could represent 30% of all outpatient visits by 2030, per McKinsey estimates. Teladoc's integrated platform, which includes AI-driven diagnostics and data analytics, positions it as a leader in this transformation. International expansion into markets like Europe and Asia, where telemedicine adoption is accelerating, adds another layer of potential. Wall Street projections suggest revenue could double in the next five years, with profitability improving as operating expenses stabilize.
Challenges include reimbursement uncertainties from insurers and competition from players like Amazon Clinic. However, Teladoc's partnerships with major employers and health plans provide a moat, ensuring steady revenue streams. With net losses narrowing and a path to positive free cash flow by 2026, the stock's current valuation screams "bargain." Investors buying now could see multi-bagger returns as the healthcare industry fully embraces virtual care.
3. Roku (ROKU): Streaming's Hidden Champion in a Content Boom
Rounding out our list is Roku Inc. (NASDAQ: ROKU), the streaming platform that's become synonymous with cord-cutting. Roku offers devices, smart TVs, and a free ad-supported channel, capitalizing on the shift from traditional cable to over-the-top (OTT) content. Despite its dominance—with over 80 million active accounts and 1.5 billion streaming hours quarterly—the stock has been hammered, trading at about $60, down 80% from its 2021 highs amid concerns over slowing user growth and ad market softness.
Roku's forward P/E stands at 25, undervalued relative to its 20%+ expected annual revenue growth. The company reported $900 million in Q2 revenue, up 15% year-over-year, fueled by advertising and platform fees. Its business model is resilient: As more consumers ditch cable, Roku's ecosystem benefits from network effects, with users spending more time on the platform, attracting advertisers.
The broader opportunity lies in the exploding streaming wars. Global OTT revenue is forecasted to hit $200 billion by 2028, per PwC, and Roku's neutral position—partnering with Netflix, Disney, and others—makes it indispensable. Innovations like shoppable ads and international expansion into Latin America and Europe are key catalysts. Analysts predict EPS to turn positive next year, with margins expanding as scale kicks in.
Potential pitfalls include economic sensitivity affecting ad budgets and competition from Apple TV or Amazon Fire. Still, Roku's debt-free balance sheet and $2 billion cash reserve provide ample runway. For growth-oriented investors, this is a stock that could easily double or triple as the digital entertainment landscape evolves.
Why These Stocks Deserve Your Attention Now
In summary, Shopify, Teladoc Health, and Roku exemplify undervalued growth stocks trading below their intrinsic worth due to temporary setbacks. Each operates in a high-growth industry with tailwinds that far outweigh near-term risks. By focusing on fundamentals—strong revenue trajectories, innovative products, and improving profitability—investors can position themselves for outsized returns. Of course, diversification and due diligence are crucial; consider your risk tolerance and consult financial advisors. As the market rebounds, these picks could lead the charge, rewarding those who buy while others hesitate. With the S&P 500 trading at elevated valuations, shifting toward these undervalued names might just be the smart move for 2025 and beyond.
This analysis highlights the importance of looking past short-term noise. Shopify's e-commerce dominance, Teladoc's telehealth revolution, and Roku's streaming prowess offer compelling narratives. Investors who acted on similar opportunities in past cycles—think Amazon in 2010 or Netflix in 2013—reaped massive gains. Could history repeat? Only time will tell, but the data suggests yes. (Word count: 1,248)
Read the Full The Motley Fool Article at:
[ https://www.fool.com/investing/2025/07/31/3-undervalued-growth-stocks-you-can-buy-now/ ]
Similar Stocks and Investing Publications
[ Yesterday Morning ]: The Motley Fool
[ Last Tuesday ]: The Motley Fool
[ Last Tuesday ]: The Motley Fool
[ Last Tuesday ]: The Motley Fool
[ Last Monday ]: Seeking Alpha
[ Last Monday ]: The Motley Fool
[ Last Saturday ]: The Motley Fool
[ Last Friday ]: The Motley Fool
[ Sat, Jul 19th ]: The Motley Fool
[ Sat, Jul 19th ]: The Motley Fool